The role of health economic evidence in the development of clinical practice guidelines_Chinese Journal of Evidence-Based Medicine

Authors：

GUO Wenhao ^1,2 , LI Yan ^1,2 , WANG Siyue ^1,2 , HU Bingqi ^1,2 ,  LI Hongchao ^1,2

1. School of International Pharmaceutical Business, China Pharmaceutical University, Nanjing 211198, P. R. China;
2. Center for Pharmacoeconomics and Outcomes Research, China Pharmaceutical University, Nanjing 211198, P. R. China;

Corresponding author：

LI Hongchao, Email: lihongchao@cpu.edu.cn

Keywords：

Health economic evidence; Clinical practice guideline; Health economic evaluation

DOI：

10.7507/1672-2531.202305121

Video：

Export PDF Favorites Scan Get Citation

Abstract Full text Figures/Tables Video References Cited by

This article aims to explore the application of health economics evidence in the development of clinical practice guidelines and evidence recommendations, and to provide better references for clinical decision-making. By reviewing the use of health economics evidence in domestic and international clinical practice guidelines, the difficulties in the application of health economics evidence in the development of clinical practice guidelines and evidence recommendations were summarized. It was found that there were significant differences in the use of health economics evidence in clinical practice guidelines in different countries, and these differences were affected by the goals of clinical practice guidelines and limitations of health economics evidence itself, lacking standardized methodological guidance, resulting in limited use of health economics evidence in clinical practice guidelines. Therefore, further research is needed to optimize the integration of health economics and clinical practice guidelines, and develop standardized methodological guidance.

Citation： GUO Wenhao, LI Yan, WANG Siyue, HU Bingqi, LI Hongchao. The role of health economic evidence in the development of clinical practice guidelines. Chinese Journal of Evidence-Based Medicine, 2024, 24(1): 91-97. doi: 10.7507/1672-2531.202305121 Copy

1.	NIH. About systematic evidence reviews and clinical practice guidelines.
2.	Institute Of Medicine (US) Committee On Clinical Practice Guidelines. Guidelines for clinical practice: from development to use. Washington DC: National Academies Press (US), 1992.
3.	Williams A. How should information of cost-effectiveness influence practice. London: BMJ, 1995.
4.	桂裕亮, 韩晟, 曾宪涛, 等. 卫生经济学评价研究方法学质量评价工具简介. 河南大学学报(医学版), 2017, 36(2): 129-132.
5.	杨钦博, 周奇, 黄天相, 等. 2017年中国大陆期刊发表的临床实践指南的报告质量评价. 中国循证医学杂志, 2019, 19(11): 1325-1332.
6.	Ramsey SD. Economic analyses and clinical practice guidelines: why not a match made in heaven. J Gen Intern Med, 2002, 17(3): 235-237.
7.	Sharlip ID, Belker AM, Honig S, et al. Vasectomy: AUA guideline. J Urol, 2012, 188(6 Suppl): 2482-2491.
8.	Schwartz JA, Pearson SD. Cost consideration in the clinical guidance documents of physician specialty societies in the United States. JAMA Intern Med, 2013, 173(12): 1091-1097.
9.	Task Force on the Low Back Pain Clinical Practice Guidelines. American Osteopathic Association guidelines for osteopathic manipulative treatment (OMT) for patients with low back pain. J Am Osteopath Assoc, 2016, 116(8): 536-549.
10.	桂裕亮, 杨亮, 曾宪涛, 等. 临床实践指南制订方法—经济学证据在指南制订中的应用. 中国循证心血管医学杂志, 2018, 10(11): 1285-1288.
11.	NICE. Safeguarding adults in care homes. 2021.
12.	Eldis. Private sector involvement in funding and providing health services in South Africa: implications for equity and access to health care.
13.	Wilkinson M, Hofman KJ, Young T, et al. Health economic evidence in clinical guidelines in South Africa: a mixed-methods study. BMC Health Serv Res, 2021, 21(1): 738.
14.	王彦博, 王强, 赵明娟, 等. 2018年中国发布临床实践指南利益冲突与经济学证据的调查分析. 医学新知, 2020, 30(2): 139-158.
15.	王强, 黄超, 李俊, 等. 2017年中国发布的临床实践指南中利益冲突与经济学证据的调查分析. 中国循证医学杂志, 2018, 18(4): 379-387.
16.	叶进, 喻闽凤, 徐卉卉, 等. 中医儿科临床诊疗指南蛔虫病(修订). 中医儿科杂志, 2017, 13(6): 6-10.
17.	陈耀龙, 杨克虎, 王小钦, 等. 中国制订/修订临床诊疗指南的指导原则(2022版). 中华医学杂志, 2022, 102(10): 697-703.
18.	Sanabria AJ, Kotzeva A, Selva Olid A, et al. Most guideline organizations lack explicit guidance in how to incorporate cost considerations. J Clin Epidemiol, 2019, 116: 72-83.
19.	刘国思. 中国药物经济学评价指南2020: 中英双语版. 北京: 中国市场出版社, 2020.
20.	Guyatt GH, Oxman AD, Montori V, 等. GRADE指南: Ⅴ. 证据质量评价—发表偏倚. 中国循证医学杂志, 2011, 11(12): 1430-1434.
21.	Cheng J, Zhang Y, Zhong A, et al. Quality of health economic evaluations in mainland China: a comparison of peer-reviewed articles in Chinese and in English. Appl Health Econ Health Policy, 2022, 20(1): 35-54.
22.	Kaplan RM. Health status and health policy: quality of life in health care evaluation and resource allocation. Qual Life Res, 1994, 3(6): 457-458.
23.	van Mastrigt GA, Hiligsmann M, Arts JJ, et al. How to prepare a systematic review of economic evaluations for informing evidence-based healthcare decisions: a five-step approach (part 1/3). Expert Rev Pharmacoecon Outcomes Res, 2016, 16(6): 689-704.
24.	Mathes T, Walgenbach M, Antoine SL, et al. Methods for systematic reviews of health economic evaluations: a systematic review, comparison, and synthesis of method literature. Med Decis Making, 2014, 34(7): 826-840.
25.	Schünemann H, Hill S, Guyatt G, et al. The GRADE approach and Bradford Hill's criteria for causation. J Epidemiol Community Health, 2011, 65(5): 392-395.
26.	National Institute for Health and Care Excellence. Developing NICE guidelines: the manual. 2015.
27.	Welte R, Feenstra T, Jager H, et al. A decision chart for assessing and improving the transferability of economic evaluation results between countries. Pharmacoeconomics, 2004, 22(13): 857-876.
28.	World Health Organization. WHO handbook for guideline development (2nd Edition).
29.	Brouwers MC, Kho ME, Browman GP, et al. AGREE Ⅱ: advancing guideline development, reporting, and evaluation in health care. Prev Med, 2010, 51(5): 421-424.
30.	靳英辉, 张林, 黄笛, 等. 临床实践指南制定方法—指南制定参与人员及组成分配. 中国循证心血管医学杂志, 2018, 10(4): 385-391.
31.	National Institute for Health and Care Excellence. The guidelines manual. London: National Institute for Health and Care Excellence (NICE), 2012.
32.	Husereau D, Drummond M, Petrou S, et al. Consolidated Health Economic Evaluation Reporting Standards (CHEERS)-explanation and elaboration: a report of the ISPOR Health Economic Evaluation Publication Guidelines Good Reporting Practices Task Force. Value Health, 2013, 16(2): 231-250.
33.	Husereau D, Drummond M, Augustovski F, 等. 卫生经济学评价报告标准共识2022 (CHEERS 2022): 卫生经济学评价报告指导意见更新版. 英国医学杂志中文版, 2022, 25(8): 460-465.
34.	Critical Appraisal Skills Programme. CASP checklists - critical appraisal skills programme.
35.	National Institute for Health and Care Excellence. Developing NICE guidelines: the manual [Internet]. London: National Institute for Health and Care Excellence (NICE), 2022.

1. NIH. About systematic evidence reviews and clinical practice guidelines.
2. Institute Of Medicine (US) Committee On Clinical Practice Guidelines. Guidelines for clinical practice: from development to use. Washington DC: National Academies Press (US), 1992.
3. Williams A. How should information of cost-effectiveness influence practice. London: BMJ, 1995.
4. 桂裕亮, 韩晟, 曾宪涛, 等. 卫生经济学评价研究方法学质量评价工具简介. 河南大学学报(医学版), 2017, 36(2): 129-132.
5. 杨钦博, 周奇, 黄天相, 等. 2017年中国大陆期刊发表的临床实践指南的报告质量评价. 中国循证医学杂志, 2019, 19(11): 1325-1332.
6. Ramsey SD. Economic analyses and clinical practice guidelines: why not a match made in heaven. J Gen Intern Med, 2002, 17(3): 235-237.
7. Sharlip ID, Belker AM, Honig S, et al. Vasectomy: AUA guideline. J Urol, 2012, 188(6 Suppl): 2482-2491.
8. Schwartz JA, Pearson SD. Cost consideration in the clinical guidance documents of physician specialty societies in the United States. JAMA Intern Med, 2013, 173(12): 1091-1097.
9. Task Force on the Low Back Pain Clinical Practice Guidelines. American Osteopathic Association guidelines for osteopathic manipulative treatment (OMT) for patients with low back pain. J Am Osteopath Assoc, 2016, 116(8): 536-549.
10. 桂裕亮, 杨亮, 曾宪涛, 等. 临床实践指南制订方法—经济学证据在指南制订中的应用. 中国循证心血管医学杂志, 2018, 10(11): 1285-1288.
11. NICE. Safeguarding adults in care homes. 2021.
12. Eldis. Private sector involvement in funding and providing health services in South Africa: implications for equity and access to health care.
13. Wilkinson M, Hofman KJ, Young T, et al. Health economic evidence in clinical guidelines in South Africa: a mixed-methods study. BMC Health Serv Res, 2021, 21(1): 738.
14. 王彦博, 王强, 赵明娟, 等. 2018年中国发布临床实践指南利益冲突与经济学证据的调查分析. 医学新知, 2020, 30(2): 139-158.
15. 王强, 黄超, 李俊, 等. 2017年中国发布的临床实践指南中利益冲突与经济学证据的调查分析. 中国循证医学杂志, 2018, 18(4): 379-387.
16. 叶进, 喻闽凤, 徐卉卉, 等. 中医儿科临床诊疗指南蛔虫病(修订). 中医儿科杂志, 2017, 13(6): 6-10.
17. 陈耀龙, 杨克虎, 王小钦, 等. 中国制订/修订临床诊疗指南的指导原则(2022版). 中华医学杂志, 2022, 102(10): 697-703.
18. Sanabria AJ, Kotzeva A, Selva Olid A, et al. Most guideline organizations lack explicit guidance in how to incorporate cost considerations. J Clin Epidemiol, 2019, 116: 72-83.
19. 刘国思. 中国药物经济学评价指南2020: 中英双语版. 北京: 中国市场出版社, 2020.
20. Guyatt GH, Oxman AD, Montori V, 等. GRADE指南: Ⅴ. 证据质量评价—发表偏倚. 中国循证医学杂志, 2011, 11(12): 1430-1434.
21. Cheng J, Zhang Y, Zhong A, et al. Quality of health economic evaluations in mainland China: a comparison of peer-reviewed articles in Chinese and in English. Appl Health Econ Health Policy, 2022, 20(1): 35-54.
22. Kaplan RM. Health status and health policy: quality of life in health care evaluation and resource allocation. Qual Life Res, 1994, 3(6): 457-458.
23. van Mastrigt GA, Hiligsmann M, Arts JJ, et al. How to prepare a systematic review of economic evaluations for informing evidence-based healthcare decisions: a five-step approach (part 1/3). Expert Rev Pharmacoecon Outcomes Res, 2016, 16(6): 689-704.
24. Mathes T, Walgenbach M, Antoine SL, et al. Methods for systematic reviews of health economic evaluations: a systematic review, comparison, and synthesis of method literature. Med Decis Making, 2014, 34(7): 826-840.
25. Schünemann H, Hill S, Guyatt G, et al. The GRADE approach and Bradford Hill's criteria for causation. J Epidemiol Community Health, 2011, 65(5): 392-395.
26. National Institute for Health and Care Excellence. Developing NICE guidelines: the manual. 2015.
27. Welte R, Feenstra T, Jager H, et al. A decision chart for assessing and improving the transferability of economic evaluation results between countries. Pharmacoeconomics, 2004, 22(13): 857-876.
28. World Health Organization. WHO handbook for guideline development (2nd Edition).
29. Brouwers MC, Kho ME, Browman GP, et al. AGREE Ⅱ: advancing guideline development, reporting, and evaluation in health care. Prev Med, 2010, 51(5): 421-424.
30. 靳英辉, 张林, 黄笛, 等. 临床实践指南制定方法—指南制定参与人员及组成分配. 中国循证心血管医学杂志, 2018, 10(4): 385-391.
31. National Institute for Health and Care Excellence. The guidelines manual. London: National Institute for Health and Care Excellence (NICE), 2012.
32. Husereau D, Drummond M, Petrou S, et al. Consolidated Health Economic Evaluation Reporting Standards (CHEERS)-explanation and elaboration: a report of the ISPOR Health Economic Evaluation Publication Guidelines Good Reporting Practices Task Force. Value Health, 2013, 16(2): 231-250.
33. Husereau D, Drummond M, Augustovski F, 等. 卫生经济学评价报告标准共识2022 (CHEERS 2022): 卫生经济学评价报告指导意见更新版. 英国医学杂志中文版, 2022, 25(8): 460-465.
34. Critical Appraisal Skills Programme. CASP checklists - critical appraisal skills programme.
35. National Institute for Health and Care Excellence. Developing NICE guidelines: the manual [Internet]. London: National Institute for Health and Care Excellence (NICE), 2022.

Chinese Journal of Evidence-Based Medicine

The role of health economic evidence in the development of clinical practice guidelines

Abstract Full text Figures/Tables Video References Cited by

Previous Article

Next Article

Format

Content